• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·China·Consumer Cyclical·6666.TW
Share

Luo Lih-Fen Holding Co., Ltd. Stocks

NT$ 42Last Updated 19.10.2026

Issuer Rating

5/7
Performance

Strong

Risk

Considerable

Recommendation

Hold

Market Cap

NT$ 62.11M

NT$ 42
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Luo Lih-Fen Holding Co., Ltd. specializes in the research, development, production, and distribution of facial beauty and cosmetic products, primarily targeting the market in Mainland China. The company offers a diverse portfolio of beauty and wellness items under various brand names, including Glingluo, Sunlily, Draise, Qiecome, Liruoya, and EasyBio. Beyond its product offerings, Luo Lih-Fen Holding also provides expert consulting for beauty and skincare, alongside services for deal management and associated staff training. Its products are distributed to beauty and cosmetic retailers via a network of dealers. Established in 2016, the company maintains its headquarters in Grand Cayman, Cayman Islands.

Company Valuation

Undervalued
6/7

Based on key historical and expected multiples, the stock is undervalued relative to its peers. Specifically, the stock is 'cheap' on P/E, undervalued on EV/EBITDA, reaso

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

19.10.2026 21:53

Apple Has Announced the Date of the Event Where It Will Unveil the First Touchscreen MacBook — Bloomberg

19.10.2026 21:49

"Davos in the Desert" has been postponed due to attacks. Fink and Solomon were scheduled to speak there.

19.10.2026 21:11

"Not all Neoclouds are the same": Experts recommend buying CoreWeave and Nebius after the market correction

19.10.2026 20:13

Silence Therapeutics soars 125% as Merck to acquire developer of blood cancer drug

19.10.2026 18:43

"A buying opportunity is emerging": Nasdaq jumped 1% after the sell-off

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026